| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1100915290 |
| P356 | DOI | 10.1186/S40478-018-0508-2 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s40478-018-0508-2 |
| P932 | PMC publication ID | 5806364 |
| P698 | PubMed publication ID | 29422107 |
| P50 | author | Bernardino F. Ghetti | Q56863342 |
| Douglas R. Galasko | Q67228424 | ||
| Byron Caughey | Q88511201 | ||
| Katrina J Campbell | Q88893396 | ||
| P2093 | author name string | Andrew G Hughson | |
| Christina D Orrù | |||
| Bradley R Groveman | |||
| Gianluigi Zanusso | |||
| Lynne D Raymond | |||
| Jiri Safar | |||
| P2860 | cites work | Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC | Q28484853 |
| Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium | Q29614409 | ||
| Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease | Q31095751 | ||
| Bank Vole Prion Protein As an Apparently Universal Substrate for RT-QuIC-Based Detection and Discrimination of Prion Strains | Q33457447 | ||
| The neuropathology of probable Alzheimer disease and mild cognitive impairment | Q33616561 | ||
| Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays | Q33769767 | ||
| Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. | Q33864626 | ||
| Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study | Q34043770 | ||
| Synucleinopathies: clinical and pathological implications | Q34140347 | ||
| Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. | Q34161515 | ||
| A test for Creutzfeldt-Jakob disease using nasal brushings | Q34293962 | ||
| MDS clinical diagnostic criteria for Parkinson's disease | Q34498274 | ||
| Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay | Q34571438 | ||
| Quantitative assessment of prion infectivity in tissues and body fluids by real-time quaking-induced conversion | Q34720803 | ||
| Prion disease blood test using immunoprecipitation and improved quaking-induced conversion | Q35006294 | ||
| Characteristic CSF prion seeding efficiency in humans with prion diseases | Q35024691 | ||
| Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid | Q35038237 | ||
| National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach | Q35706615 | ||
| Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion | Q35960528 | ||
| Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease | Q36281277 | ||
| Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein | Q36321556 | ||
| Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines | Q36810589 | ||
| Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. | Q37307515 | ||
| Establishing quantitative real-time quaking-induced conversion (qRT-QuIC) for highly sensitive detection and quantification of PrPSc in prion-infected tissues. | Q37485455 | ||
| Primary progressive aphasia: clinicopathological correlations | Q37688883 | ||
| Cerebrospinal fluid biomarkers in Parkinson disease | Q38082586 | ||
| How many biomarkers to discriminate neurodegenerative dementia? | Q38570242 | ||
| A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations | Q38653383 | ||
| Diagnosis of Human Prion Disease Using Real-Time Quaking-Induced Conversion Testing of Olfactory Mucosa and Cerebrospinal Fluid Samples | Q38784162 | ||
| Duration and Pathologic Correlates of Lewy Body Disease | Q39004053 | ||
| Prion-Like Seeding of Misfolded α-Synuclein in the Brains of Dementia with Lewy Body Patients in RT-QUIC. | Q40196812 | ||
| Diagnostic and prognostic value of human prion detection in cerebrospinal fluid | Q40433329 | ||
| Early detection of chronic wasting disease prions in urine of pre-symptomatic deer by real-time quaking-induced conversion assay. | Q41900931 | ||
| Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies | Q42442006 | ||
| Sequence determinants regulating fibrillation of human alpha-synuclein | Q46762879 | ||
| Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid. | Q48405878 | ||
| Why does Coomassie Brilliant Blue R interact differently with different proteins? A partial answer. | Q50914743 | ||
| A Test for Creutzfeldt–Jakob Disease Using Nasal Brushings | Q59505789 | ||
| Formation and Characterization of α-Synuclein Oligomers | Q86433702 | ||
| P433 | issue | 1 | |
| P921 | main subject | cerebrospinal fluid | Q54196 |
| Synuclein | Q24767155 | ||
| RT-QuIC | Q64157236 | ||
| P304 | page(s) | 7 | |
| P577 | publication date | 2018-02-09 | |
| P1433 | published in | Acta Neuropathologica Communications | Q27724912 |
| P1476 | title | Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC. | |
| P478 | volume | 6 |
| Q90736880 | 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration |
| Q64085064 | A proteomic signature for dementia with Lewy bodies |
| Q89842746 | A single ultrasensitive assay for detection and discrimination of tau aggregates of Alzheimer and Pick diseases |
| Q93164263 | An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders |
| Q64077907 | Application of PMCA to screen for prion infection in a human cell line used to produce biological therapeutics |
| Q55307741 | Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as Diagnostic Tools. |
| Q91595666 | Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies |
| Q93075108 | CSF and blood biomarkers for Parkinson's disease |
| Q64057961 | Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease |
| Q64060892 | Comparison of conventional, amplification and bio-assay detection methods for a chronic wasting disease inoculum pool |
| Q89557172 | Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy |
| Q92981315 | Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays |
| Q92580229 | Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson's disease and multiple system atrophy |
| Q99413997 | From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins |
| Q64814709 | Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases |
| Q91967822 | PAD-Beads enrichment enhances detection of PrPSc using real-time quaking-induced conversion |
| Q90163542 | PMCA Applications for Prion Detection in Peripheral Tissues of Patients with Variant Creutzfeldt-Jakob Disease |
| Q89945308 | Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg |
| Q90453561 | Potential sources of interference with the highly sensitive detection and quantification of alpha-synuclein seeds by qRT-QuIC |
| Q92115905 | Preclinical Detection of Prions in Blood of Nonhuman Primates Infected with Variant Creutzfeldt-Jakob Disease |
| Q91637190 | Prion-Like Mechanisms in Parkinson's Disease |
| Q89634915 | RT-QuIC-based detection of alpha-synuclein seeding activity in brains of dementia with Lewy Body patients and of a transgenic mouse model of synucleinopathy |
| Q64760145 | Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054 |
| Q58572579 | Recent Advances in Biomarkers for Parkinson's Disease |
| Q90664222 | Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease |
| Q64814715 | The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders. |
| Q64052834 | Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid |
| Q92017939 | What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson's Disease Patients and Healthy Subjects with Parkinson's-Associated LRRK2 Mutations? |
| Q90625424 | α-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies |
| Q64778989 | α-Synuclein real-time quaking-induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism |
Search more.